Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kozo Morimoto

Showing results (171-180 of 191) with videos related to

Pageof 20
Sort By:
Pulmonary Therapy|April 8, 2025
Trial Conduct, Baseline Characteristics, and Symptom Burden of Patients in the ARISE StudyCharles L Daley, James D Chalmers, Patrick A Flume, et al.
Respiratory Investigation|January 22, 2026
Clinical characteristics and severity of primary ciliary dyskinesia caused by large homozygous deletion including exons 1-4 of DRC1: A multicenter retrospective cohort studyMasashi Ito, Atsuko Nakano, Yukiko Arimoto, et al.
Emerging Infectious Diseases|March 2, 2025
Identification of 2 Novel Species, Mycobacterium novusgordonae and M. shingordonaeKazuki Hashimoto, Yuko Abe, Kiyoharu Fukushima, et al.
Plos One|April 26, 2019
Retrospective evaluation of natural course in mild cases of Mycobacterium avium complex pulmonary diseaseYoshifumi Kimizuka, Yoshihiko Hoshino, Tomoyasu Nishimura, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 6, 2024
Distinctive clinical features of radiological pleuroparenchymal fibroelastosis with nontuberculous mycobacterial pulmonary disease: A multicenter retrospective cohort studyHiromu Tanaka, Takanori Asakura, Satoshi Okamori, et al.
Tuberculosis (Edinburgh, Scotland)|January 27, 2023
Environmental risk of nontuberculous mycobacterial infection: Strategies for advancing methodologyRachel A Mercaldo, Julia E Marshall, Gerard A Cangelosi, et al.
Chest|April 22, 2021
Amikacin Liposome Inhalation Suspension for Refractory Mycobacterium avium Complex Lung Disease: Sustainability and Durability of Culture Conversion and Safety of Long-term ExposureDavid E Griffith, Rachel Thomson, Patrick A Flume, et al.
Annals of the American Thoracic Society|December 16, 2020
Amikacin Liposome Inhalation Suspension for <i>Mycobacterium avium</i> Complex Lung Disease: A 12-Month Open-Label Extension Clinical TrialKevin L Winthrop, Patrick A Flume, Rachel Thomson, et al.
Medrxiv : the Preprint Server for Health Sciences|July 10, 2026
Incidence trends of nontuberculous mycobacterial pulmonary infections in Australia, Cambodia, Japan, Thailand, and the United StatesAtha R Pradana, Melinda M Ashcroft, Pichanee Watthanasiri, et al.
Annals of the American Thoracic Society|March 28, 2025
Intermittent versus Daily Therapy for Noncavitary <i>Mycobacterium avium</i> Complex Pulmonary Disease: An Open-label Randomized TrialTaku Nakagawa, Kohei Fujita, Mari Miki, et al.
Pageof 20

Showing results (171-180 of 191) with videos related to

Sort By:
Pageof 20
Pulmonary Therapy|April 8, 2025
Trial Conduct, Baseline Characteristics, and Symptom Burden of Patients in the ARISE StudyCharles L Daley, James D Chalmers, Patrick A Flume, et al.
Respiratory Investigation|January 22, 2026
Clinical characteristics and severity of primary ciliary dyskinesia caused by large homozygous deletion including exons 1-4 of DRC1: A multicenter retrospective cohort studyMasashi Ito, Atsuko Nakano, Yukiko Arimoto, et al.
Emerging Infectious Diseases|March 2, 2025
Identification of 2 Novel Species, Mycobacterium novusgordonae and M. shingordonaeKazuki Hashimoto, Yuko Abe, Kiyoharu Fukushima, et al.
Plos One|April 26, 2019
Retrospective evaluation of natural course in mild cases of Mycobacterium avium complex pulmonary diseaseYoshifumi Kimizuka, Yoshihiko Hoshino, Tomoyasu Nishimura, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 6, 2024
Distinctive clinical features of radiological pleuroparenchymal fibroelastosis with nontuberculous mycobacterial pulmonary disease: A multicenter retrospective cohort studyHiromu Tanaka, Takanori Asakura, Satoshi Okamori, et al.
Tuberculosis (Edinburgh, Scotland)|January 27, 2023
Environmental risk of nontuberculous mycobacterial infection: Strategies for advancing methodologyRachel A Mercaldo, Julia E Marshall, Gerard A Cangelosi, et al.
Chest|April 22, 2021
Amikacin Liposome Inhalation Suspension for Refractory Mycobacterium avium Complex Lung Disease: Sustainability and Durability of Culture Conversion and Safety of Long-term ExposureDavid E Griffith, Rachel Thomson, Patrick A Flume, et al.
Annals of the American Thoracic Society|December 16, 2020
Amikacin Liposome Inhalation Suspension for <i>Mycobacterium avium</i> Complex Lung Disease: A 12-Month Open-Label Extension Clinical TrialKevin L Winthrop, Patrick A Flume, Rachel Thomson, et al.
Medrxiv : the Preprint Server for Health Sciences|July 10, 2026
Incidence trends of nontuberculous mycobacterial pulmonary infections in Australia, Cambodia, Japan, Thailand, and the United StatesAtha R Pradana, Melinda M Ashcroft, Pichanee Watthanasiri, et al.
Annals of the American Thoracic Society|March 28, 2025
Intermittent versus Daily Therapy for Noncavitary <i>Mycobacterium avium</i> Complex Pulmonary Disease: An Open-label Randomized TrialTaku Nakagawa, Kohei Fujita, Mari Miki, et al.
Pageof 20